The proposed acquisition terms grant RXO shareholders $17.25 in cash plus 0.0856 shares of C.H. Robinson Worldwide stock for each share held. Ademi LLP is currently reviewing the transaction to determine if these terms adequately reflect RXO's long-term growth prospects or if the board failed to prioritize the interests of public shareholders during negotiations.

Key areas of concern include substantial change-of-control payouts reserved for company insiders and restrictive provisions, such as significant termination penalties, that could discourage superior offers from third parties. Shareholders are being encouraged to come forward to discuss their rights, as the firm examines whether the board fulfilled its fiduciary obligations throughout the deal-making process.